Literature DB >> 29930805

Detection of HERV-K6 and HERV-K11 transpositions in the human genome.

Buket Cakmak Guner1, Elif Karlik2, Sevgi Marakli1, Nermin Gozukirmizi1.   

Abstract

Mobile genetic elements classed as transposons comprise an estimated 45% of the human genome, and 8% of these elements are human endogenous retroviruses (HERVs). Endogenous retroviruses are retrotransposons, containing 5' and 3' long terminal repeat sequences and encoding envelope, group-specific antigen and DNA polymerase proteins. The aim of the present study was to analyse genome integration polymorphisms of HERV type K member 6 (HERV-K6) and HERV-K11 by using the retrotransposon based molecular marker technique, inter-retrotransposon amplified polymorphism (IRAP). For this purpose, blood samples of 18 healthy individuals within the age range of 10-79 years (10 females and 8 males) were collected, genomic DNAs were isolated and IRAP-polymerase chain reaction (PCR) was performed. IRAP-PCR analyses demonstrated that there were 0-70% polymorphism rates for HERV-K6, and 0-38% polymorphism rates for HERV-K11 among all the samples. Furthermore, the polymorphism rates were 0-70% among females and 11-60% among males for HERV-K6, and 0-38% among females and 0-25% among males for HERV-K11. Age-associated polymorphism was also investigated, but no age-associated polymorphism was observed among the samples. Therefore, HERV-K6 and HERV-K11 polymorphisms may arise on an individual-specific basis. Various previous studies have investigated the associations between the expression of HERVs and cancer or other major diseases. However, few reports have analysed HERV-K movements among individuals. This is the first report to investigate HERV-K6 and HERV-K11 retrotransposon polymorphisms between the genders and different age groups.

Entities:  

Keywords:  human endogenous retrovirus type K; human genome; mobile genetic elements; polymorphism

Year:  2018        PMID: 29930805      PMCID: PMC6007044          DOI: 10.3892/br.2018.1096

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  26 in total

1.  Expression of the pol gene of human endogenous retroviruses HERV-K and -W in leukemia patients.

Authors:  Massimiliano Bergallo; Paola Montanari; Katia Mareschi; Chiara Merlino; Massimo Berger; Ilaria Bini; Valentina Daprà; Ilaria Galliano; Franca Fagioli
Journal:  Arch Virol       Date:  2017-08-18       Impact factor: 2.574

2.  Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity.

Authors:  Robert Belshaw; Anna L A Dawson; John Woolven-Allen; Joanna Redding; Austin Burt; Michael Tristem
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.

Authors:  Maria Suntsova; Elena V Gogvadze; Sergey Salozhin; Nurshat Gaifullin; Fedor Eroshkin; Sergey E Dmitriev; Natalia Martynova; Kirill Kulikov; Galina Malakhova; Gulnur Tukhbatova; Alexey P Bolshakov; Dmitry Ghilarov; Andrew Garazha; Alexander Aliper; Charles R Cantor; Yuri Solokhin; Sergey Roumiantsev; Pavel Balaban; Alex Zhavoronkov; Anton Buzdin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 4.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

5.  L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism.

Authors:  Hiroki Kano; Irene Godoy; Christine Courtney; Melissa R Vetter; George L Gerton; Eric M Ostertag; Haig H Kazazian
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

6.  Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth.

Authors:  Ming Li; Laszlo Radvanyi; Bingnan Yin; Kiera Rycaj; Jia Li; Raghavender Chivukula; Kevin Lin; Yue Lu; JianJun Shen; David Z Chang; Donghui Li; Gary L Johanning; Feng Wang-Johanning
Journal:  Clin Cancer Res       Date:  2017-07-05       Impact factor: 12.531

7.  Assessment of retroviral activity using a universal retrovirus chip.

Authors:  Wolfgang Seifarth; Birgit Spiess; Udo Zeilfelder; Cornelia Speth; Rüdiger Hehlmann; Christine Leib-Mösch
Journal:  J Virol Methods       Date:  2003-09       Impact factor: 2.014

8.  Unfixed endogenous retroviral insertions in the human population.

Authors:  Emanuele Marchi; Alex Kanapin; Gkikas Magiorkinis; Robert Belshaw
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 9.  Epigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs).

Authors:  Tara P Hurst; Gkikas Magiorkinis
Journal:  Viruses       Date:  2017-05-31       Impact factor: 5.048

Review 10.  Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice?

Authors:  Ronan F Downey; Francis J Sullivan; Feng Wang-Johanning; Stefan Ambs; Francis J Giles; Sharon A Glynn
Journal:  Int J Cancer       Date:  2014-06-17       Impact factor: 7.396

View more
  4 in total

Review 1.  Gene transfer to plants by electroporation: methods and applications.

Authors:  Ibrahim Ilker Ozyigit
Journal:  Mol Biol Rep       Date:  2020-04-02       Impact factor: 2.316

Review 2.  Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders.

Authors:  Emanuela Balestrieri; Claudia Matteucci; Chiara Cipriani; Sandro Grelli; Laura Ricceri; Gemma Calamandrei; Paola Sinibaldi Vallebona
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

Review 3.  Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression?

Authors:  Eros Di Giorgio; Luigi E Xodo
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 4.  Microfluidics as a Novel Tool for Biological and Toxicological Assays in Drug Discovery Processes: Focus on Microchip Electrophoresis.

Authors:  Giuseppe Caruso; Nicolò Musso; Margherita Grasso; Angelita Costantino; Giuseppe Lazzarino; Fabio Tascedda; Massimo Gulisano; Susan M Lunte; Filippo Caraci
Journal:  Micromachines (Basel)       Date:  2020-06-15       Impact factor: 2.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.